Purified anti-mouse CD3 Antibody Purified anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_Pure_021606
C57BL/6 mouse splenocytes stained with purified 17A2, followed by anti-rat IgG FITC
  • 17A2_Pure_021606
    C57BL/6 mouse splenocytes stained with purified 17A2, followed by anti-rat IgG FITC
  • 17A2_Pure_CD3_Antibody_2_102418
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then, the section was stained with 10 µg/mL of Purified CD3 (clone 17A2) and Alexa Fluor® 488 anti-mouse/human CD45R/B220 antibody (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 anti-rat IgG2b (clone MRG2b-85) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 17A2_Pure_CD3_Antibody_3_102418
    Fresh, frozen mouse spleen was stained with purified CD3 clone 17A2 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100201 50 µg SEK252
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100202 500 µg SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, ICC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µl volume. For immunohistochemistry on frozen tissue sections, a concentration of 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  2. Abdel-Gadir A, et al. 2019. Nat Med. 25:1164. PubMed
  3. Hamada T, et al. 2008. J Immunol. 180:1843. PubMed
  4. Bernstein DL, et al. 2020. Brain Behav Immun. 87:543. PubMed
  5. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  6. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  7. Li TT, et al. 2021. BMC Immunol. 22:55. PubMed
  8. Lu X, et al. 2021. J Exp Med. 218: . PubMed
  9. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  10. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  13. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  14. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  15. Glaubitz J, et al. 2023. Gut. :. PubMed
  16. Fueyo-González F, et al. 2022. Immunity. 55:459. PubMed
  17. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  18. Robles-Valero J, et al. 2022. Mol Oncol. 16:3533. PubMed
  19. Mammadli M, et al. 2023. Int J Mol Sci. 24:. PubMed
  20. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  21. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  22. Xiao J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:386. PubMed
  23. Bergstrom K, et al. 2008. Infect Immun. 76:796. PubMed
  24. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  25. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  26. Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed
  27. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  28. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  29. Kulkarni NN, et al. 2020. J Invest Dermatol. 140:645. PubMed
  30. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  31. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  32. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  33. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  34. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  35. Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed
  36. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  37. Haque M, et al. 2021. Viruses. 13:. PubMed
  38. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  39. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  40. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  41. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  42. Kerdidani D, et al. 2019. Nat Commun. 10:1405. PubMed
  43. Hayashi Y, et al. 2017. J Cancer. 8:2478. PubMed
  44. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  45. Boothby IC, et al. 2021. Nature. 599:667. PubMed
  46. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  47. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  48. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  49. Chen Y, et al. 2018. Oncoimmunology. 7:e1388484. PubMed
  50. Child KM et al. 2018. The Journal of Neuroscience. 38(31):6806-6824 . PubMed
  51. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  52. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  53. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  54. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  55. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  56. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  57. Yoshihara T, et al. 2020. Gut Microbes. 11:1385. PubMed
  58. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  59. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  60. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  61. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  62. Forsyth KS, et al. 2020. PLoS Pathog. 16:e1008685. PubMed
  63. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  64. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  65. Kopec A, et al. 2014. Toxicol Sci. 141:515. PubMed
  66. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  67. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  68. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  69. Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed
  70. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  71. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  72. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  73. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  74. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  75. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  76. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  77. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  78. You X, et al. 2022. Front Genet. 12:790990. PubMed
  79. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  80. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  81. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  82. Fitzpatrick E, et al. 2017. PLoS One. 10.1371/journal.pone.0169273. PubMed
  83. Williams SK, et al. 2018. Sci Rep. 8:13628. PubMed
  84. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  85. Sugita S, et al. 2017. Arthritis Res Ther. 19:176. PubMed
  86. Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed
  87. Karhadkar TR, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 318:L165. PubMed
  88. Morgado P, et al. 2011. Infect Immun. 79:4401. PubMed
  89. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  90. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  91. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  92. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  93. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  94. Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed
  95. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  96. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  97. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  98. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  99. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  100. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  101. Tilley S, et al. 2007. J Immunol . 178:3208. PubMed
  102. Kang LJ, et al. 2020. Sci Rep. 10:5603. PubMed
  103. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  104. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  105. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  106. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  107. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  108. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  109. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  110. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  111. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  112. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  113. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  114. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  115. He Y, et al. 2021. eLife. 10:00. PubMed
  116. Gonzales C, et al. 2016. PLoS One. 11:e0164557. PubMed
  117. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  118. Rastelli D, et al. 2021. J Clin Invest. :e150789. PubMed
  119. Moretti FA, et al. 2021. Sci Rep. 11:23221. PubMed
  120. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  121. Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed
  122. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  123. Yadav A, et al. 2009. Am J Physiol Renal Physiol. 298:734. PubMed
  124. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  125. Egaña–Gorroño L, et al. 2019. Atherosclerosis. 289:184. PubMed
  126. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  127. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  128. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  129. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  130. Abdel-Gadir A, et al. 2019. Nat Med. 25:1164. PubMed
  131. Hamada T, et al. 2008. J Immunol. 180:1843. PubMed
  132. Bernstein DL, et al. 2020. Brain Behav Immun. 87:543. PubMed
  133. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  134. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  135. Li TT, et al. 2021. BMC Immunol. 22:55. PubMed
  136. Lu X, et al. 2021. J Exp Med. 218: . PubMed
  137. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  138. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  139. Campisi L, et al. 2022. Nature. 606:945. PubMed
  140. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  141. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  142. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  143. Glaubitz J, et al. 2023. Gut. :. PubMed
  144. Fueyo-González F, et al. 2022. Immunity. 55:459. PubMed
  145. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  146. Robles-Valero J, et al. 2022. Mol Oncol. 16:3533. PubMed
  147. Mammadli M, et al. 2023. Int J Mol Sci. 24:. PubMed
  148. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  149. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  150. Xiao J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:386. PubMed
  151. Bergstrom K, et al. 2008. Infect Immun. 76:796. PubMed
  152. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  153. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  154. Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed
  155. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  156. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  157. Kulkarni NN, et al. 2020. J Invest Dermatol. 140:645. PubMed
  158. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  159. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  160. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  161. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  162. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  163. Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed
  164. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  165. Haque M, et al. 2021. Viruses. 13:. PubMed
  166. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  167. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  168. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  169. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  170. Kerdidani D, et al. 2019. Nat Commun. 10:1405. PubMed
  171. Hayashi Y, et al. 2017. J Cancer. 8:2478. PubMed
  172. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  173. Boothby IC, et al. 2021. Nature. 599:667. PubMed
  174. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  175. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  176. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  177. Chen Y, et al. 2018. Oncoimmunology. 7:e1388484. PubMed
  178. Child KM et al. 2018. The Journal of Neuroscience. 38(31):6806-6824 . PubMed
  179. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  180. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  181. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  182. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  183. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  184. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  185. Yoshihara T, et al. 2020. Gut Microbes. 11:1385. PubMed
  186. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  187. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  188. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  189. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  190. Forsyth KS, et al. 2020. PLoS Pathog. 16:e1008685. PubMed
  191. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  192. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  193. Kopec A, et al. 2014. Toxicol Sci. 141:515. PubMed
  194. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  195. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  196. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  197. Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed
  198. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  199. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  200. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  201. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  202. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  203. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  204. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  205. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  206. You X, et al. 2022. Front Genet. 12:790990. PubMed
  207. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  208. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  209. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  210. Fitzpatrick E, et al. 2017. PLoS One. 10.1371/journal.pone.0169273. PubMed
  211. Williams SK, et al. 2018. Sci Rep. 8:13628. PubMed
  212. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  213. Sugita S, et al. 2017. Arthritis Res Ther. 19:176. PubMed
  214. Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed
  215. Karhadkar TR, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 318:L165. PubMed
  216. Morgado P, et al. 2011. Infect Immun. 79:4401. PubMed
  217. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  218. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  219. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  220. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  221. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  222. Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed
  223. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  224. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  225. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  226. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  227. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  228. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  229. Tilley S, et al. 2007. J Immunol . 178:3208. PubMed
  230. Kang LJ, et al. 2020. Sci Rep. 10:5603. PubMed
  231. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  232. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  233. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  234. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  235. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  236. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  237. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  238. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  239. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  240. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  241. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  242. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  243. He Y, et al. 2021. eLife. 10:00. PubMed
  244. Gonzales C, et al. 2016. PLoS One. 11:e0164557. PubMed
  245. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  246. Rastelli D, et al. 2021. J Clin Invest. :e150789. PubMed
  247. Moretti FA, et al. 2021. Sci Rep. 11:23221. PubMed
  248. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  249. Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed
  250. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  251. Yadav A, et al. 2009. Am J Physiol Renal Physiol. 298:734. PubMed
  252. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  253. Egaña–Gorroño L, et al. 2019. Atherosclerosis. 289:184. PubMed
  254. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  255. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  256. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312658 (BioLegend Cat. No. 100201)
AB_312659 (BioLegend Cat. No. 100202)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD3 17A2 FC,IHC-F
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Test 17A2 5 17A2
FITC anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
PE/Fire™ 700 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
APC/Fire™ 810 anti-mouse CD3 17A2 FC
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
PE anti-mouse CD3 17A2 FC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 3    Revision Date: 01-04-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_Pure_021606
C57BL/6 mouse splenocytes stained with purified 17A2, followed by anti-rat IgG FITC
  • 17A2_Pure_021606
    C57BL/6 mouse splenocytes stained with purified 17A2, followed by anti-rat IgG FITC
  • 17A2_Pure_CD3_Antibody_2_102418
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then, the section was stained with 10 µg/mL of Purified CD3 (clone 17A2) and Alexa Fluor® 488 anti-mouse/human CD45R/B220 antibody (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 anti-rat IgG2b (clone MRG2b-85) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 17A2_Pure_CD3_Antibody_3_102418
    Fresh, frozen mouse spleen was stained with purified CD3 clone 17A2 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100201 50 µg SEK252
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100202 500 µg SEK790
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, ICC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µl volume. For immunohistochemistry on frozen tissue sections, a concentration of 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  2. Abdel-Gadir A, et al. 2019. Nat Med. 25:1164. PubMed
  3. Hamada T, et al. 2008. J Immunol. 180:1843. PubMed
  4. Bernstein DL, et al. 2020. Brain Behav Immun. 87:543. PubMed
  5. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  6. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  7. Li TT, et al. 2021. BMC Immunol. 22:55. PubMed
  8. Lu X, et al. 2021. J Exp Med. 218: . PubMed
  9. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  10. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  13. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  14. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  15. Glaubitz J, et al. 2023. Gut. :. PubMed
  16. Fueyo-González F, et al. 2022. Immunity. 55:459. PubMed
  17. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  18. Robles-Valero J, et al. 2022. Mol Oncol. 16:3533. PubMed
  19. Mammadli M, et al. 2023. Int J Mol Sci. 24:. PubMed
  20. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  21. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  22. Xiao J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:386. PubMed
  23. Bergstrom K, et al. 2008. Infect Immun. 76:796. PubMed
  24. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  25. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  26. Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed
  27. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  28. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  29. Kulkarni NN, et al. 2020. J Invest Dermatol. 140:645. PubMed
  30. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  31. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  32. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  33. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  34. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  35. Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed
  36. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  37. Haque M, et al. 2021. Viruses. 13:. PubMed
  38. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  39. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  40. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  41. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  42. Kerdidani D, et al. 2019. Nat Commun. 10:1405. PubMed
  43. Hayashi Y, et al. 2017. J Cancer. 8:2478. PubMed
  44. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  45. Boothby IC, et al. 2021. Nature. 599:667. PubMed
  46. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  47. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  48. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  49. Chen Y, et al. 2018. Oncoimmunology. 7:e1388484. PubMed
  50. Child KM et al. 2018. The Journal of Neuroscience. 38(31):6806-6824 . PubMed
  51. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  52. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  53. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  54. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  55. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  56. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  57. Yoshihara T, et al. 2020. Gut Microbes. 11:1385. PubMed
  58. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  59. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  60. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  61. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  62. Forsyth KS, et al. 2020. PLoS Pathog. 16:e1008685. PubMed
  63. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  64. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  65. Kopec A, et al. 2014. Toxicol Sci. 141:515. PubMed
  66. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  67. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  68. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  69. Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed
  70. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  71. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  72. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  73. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  74. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  75. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  76. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  77. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  78. You X, et al. 2022. Front Genet. 12:790990. PubMed
  79. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  80. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  81. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  82. Fitzpatrick E, et al. 2017. PLoS One. 10.1371/journal.pone.0169273. PubMed
  83. Williams SK, et al. 2018. Sci Rep. 8:13628. PubMed
  84. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  85. Sugita S, et al. 2017. Arthritis Res Ther. 19:176. PubMed
  86. Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed
  87. Karhadkar TR, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 318:L165. PubMed
  88. Morgado P, et al. 2011. Infect Immun. 79:4401. PubMed
  89. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  90. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  91. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  92. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  93. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  94. Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed
  95. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  96. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  97. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  98. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  99. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  100. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  101. Tilley S, et al. 2007. J Immunol . 178:3208. PubMed
  102. Kang LJ, et al. 2020. Sci Rep. 10:5603. PubMed
  103. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  104. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  105. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  106. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  107. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  108. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  109. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  110. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  111. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  112. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  113. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  114. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  115. He Y, et al. 2021. eLife. 10:00. PubMed
  116. Gonzales C, et al. 2016. PLoS One. 11:e0164557. PubMed
  117. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  118. Rastelli D, et al. 2021. J Clin Invest. :e150789. PubMed
  119. Moretti FA, et al. 2021. Sci Rep. 11:23221. PubMed
  120. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  121. Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed
  122. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  123. Yadav A, et al. 2009. Am J Physiol Renal Physiol. 298:734. PubMed
  124. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  125. Egaña–Gorroño L, et al. 2019. Atherosclerosis. 289:184. PubMed
  126. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  127. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  128. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  129. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  130. Abdel-Gadir A, et al. 2019. Nat Med. 25:1164. PubMed
  131. Hamada T, et al. 2008. J Immunol. 180:1843. PubMed
  132. Bernstein DL, et al. 2020. Brain Behav Immun. 87:543. PubMed
  133. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  134. Doll JR, et al. 2020. PLoS Pathog. 16:e1008296. PubMed
  135. Li TT, et al. 2021. BMC Immunol. 22:55. PubMed
  136. Lu X, et al. 2021. J Exp Med. 218: . PubMed
  137. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  138. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  139. Campisi L, et al. 2022. Nature. 606:945. PubMed
  140. Halin C, et al. 2022. EMBO J. 41:e111528. PubMed
  141. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  142. Zhao J, et al. 2022. J Clin Invest. 132: . PubMed
  143. Glaubitz J, et al. 2023. Gut. :. PubMed
  144. Fueyo-González F, et al. 2022. Immunity. 55:459. PubMed
  145. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  146. Robles-Valero J, et al. 2022. Mol Oncol. 16:3533. PubMed
  147. Mammadli M, et al. 2023. Int J Mol Sci. 24:. PubMed
  148. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  149. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  150. Xiao J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:386. PubMed
  151. Bergstrom K, et al. 2008. Infect Immun. 76:796. PubMed
  152. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  153. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  154. Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed
  155. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  156. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  157. Kulkarni NN, et al. 2020. J Invest Dermatol. 140:645. PubMed
  158. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  159. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  160. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  161. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  162. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  163. Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed
  164. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  165. Haque M, et al. 2021. Viruses. 13:. PubMed
  166. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  167. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  168. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  169. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  170. Kerdidani D, et al. 2019. Nat Commun. 10:1405. PubMed
  171. Hayashi Y, et al. 2017. J Cancer. 8:2478. PubMed
  172. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  173. Boothby IC, et al. 2021. Nature. 599:667. PubMed
  174. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  175. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  176. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  177. Chen Y, et al. 2018. Oncoimmunology. 7:e1388484. PubMed
  178. Child KM et al. 2018. The Journal of Neuroscience. 38(31):6806-6824 . PubMed
  179. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  180. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  181. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  182. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  183. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  184. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  185. Yoshihara T, et al. 2020. Gut Microbes. 11:1385. PubMed
  186. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  187. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  188. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  189. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  190. Forsyth KS, et al. 2020. PLoS Pathog. 16:e1008685. PubMed
  191. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  192. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  193. Kopec A, et al. 2014. Toxicol Sci. 141:515. PubMed
  194. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  195. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  196. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  197. Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed
  198. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  199. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  200. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  201. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  202. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  203. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  204. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  205. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  206. You X, et al. 2022. Front Genet. 12:790990. PubMed
  207. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  208. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  209. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  210. Fitzpatrick E, et al. 2017. PLoS One. 10.1371/journal.pone.0169273. PubMed
  211. Williams SK, et al. 2018. Sci Rep. 8:13628. PubMed
  212. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  213. Sugita S, et al. 2017. Arthritis Res Ther. 19:176. PubMed
  214. Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed
  215. Karhadkar TR, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 318:L165. PubMed
  216. Morgado P, et al. 2011. Infect Immun. 79:4401. PubMed
  217. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  218. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  219. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  220. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  221. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  222. Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed
  223. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  224. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  225. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  226. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  227. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  228. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  229. Tilley S, et al. 2007. J Immunol . 178:3208. PubMed
  230. Kang LJ, et al. 2020. Sci Rep. 10:5603. PubMed
  231. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  232. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  233. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  234. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  235. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  236. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  237. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  238. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  239. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  240. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  241. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  242. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  243. He Y, et al. 2021. eLife. 10:00. PubMed
  244. Gonzales C, et al. 2016. PLoS One. 11:e0164557. PubMed
  245. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  246. Rastelli D, et al. 2021. J Clin Invest. :e150789. PubMed
  247. Moretti FA, et al. 2021. Sci Rep. 11:23221. PubMed
  248. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  249. Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed
  250. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  251. Yadav A, et al. 2009. Am J Physiol Renal Physiol. 298:734. PubMed
  252. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  253. Egaña–Gorroño L, et al. 2019. Atherosclerosis. 289:184. PubMed
  254. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  255. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  256. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312658 (BioLegend Cat. No. 100201)
AB_312659 (BioLegend Cat. No. 100202)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD3 17A2 FC,IHC-F
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Test 17A2 5 17A2
FITC anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
PE/Fire™ 700 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
APC/Fire™ 810 anti-mouse CD3 17A2 FC
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
PE anti-mouse CD3 17A2 FC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 3    Revision Date: 01-04-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account